Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Grows By 600.0%

BioSyent Inc. (OTCMKTS:BIOYF) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 1,400 shares, an increase of 600.0% from the June 15th total of 200 shares. Based on an average daily volume of 1,500 shares, the short-interest ratio is presently 0.9 days.

BioSyent Trading Up 0.1 %

BIOYF traded up $0.01 during midday trading on Thursday, reaching $7.50. 100 shares of the company’s stock traded hands, compared to its average volume of 2,556. BioSyent has a 52 week low of $5.54 and a 52 week high of $7.76. The firm has a fifty day moving average of $6.86 and a two-hundred day moving average of $6.57.

BioSyent Cuts Dividend

The firm also recently announced a dividend, which was paid on Saturday, June 15th. Investors of record on Monday, June 3rd were issued a dividend of $0.0331 per share. The ex-dividend date was Friday, May 31st. This represents a dividend yield of 2.02%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.